Xiaoyun Liao

8.7k total citations · 3 hit papers
69 papers, 6.2k citations indexed

About

Xiaoyun Liao is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaoyun Liao has authored 69 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 25 papers in Molecular Biology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaoyun Liao's work include Genetic factors in colorectal cancer (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (8 papers). Xiaoyun Liao is often cited by papers focused on Genetic factors in colorectal cancer (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (8 papers). Xiaoyun Liao collaborates with scholars based in United States, China and Japan. Xiaoyun Liao's co-authors include Charles S. Fuchs, Mai Yamauchi, Shuji Ogino, Aya Kuchiba, Yu Imamura, Teppei Morikawa, Zhi Rong Qian, Reiko Nishihara, Paul Lochhead and Andrew T. Chan and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Xiaoyun Liao

66 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy

2013 1.1k citations Reiko Nishihara, Kana Wu et al. profile →
Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival

2012 602 citations Xiaoyun Liao, Paul Lochhead et al. profile →
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

2012 427 citations Mai Yamauchi, Teppei Morikawa et al. profile →

Peers

Countries citing papers authored by Xiaoyun Liao

Since Specialization

Citations

This map shows the geographic impact of Xiaoyun Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyun Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyun Liao more than expected).

Fields of papers citing papers by Xiaoyun Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyun Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyun Liao. The network helps show where Xiaoyun Liao may publish in the future.

Co-authorship network of co-authors of Xiaoyun Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyun Liao. A scholar is included among the top collaborators of Xiaoyun Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyun Liao. Xiaoyun Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Matrix stiffness regulates NPC invasiveness by modulating a mechanoresponsive TRPV4-Nox4-IL-8 signaling axis 2025 ·Journal of Cancer ·Peng Zhang, (unknown), Kang Li, Jin Z. Zhang, (unknown), Fang Ma, Xiaoyun Liao, Shumei Ma, Xianhai Zeng, Xiangmin Zhang	1
2	Induction of interleukin-6 by SPZ1-mediated Wnt5a signaling boosts progression of nasopharyngeal carcinoma cells 2024 ·Journal of Cancer ·Xiaoxia Zeng, (unknown), Shuo Li, Jing Zhang, Di Qin, Zhen Wang, Fang Ma, Xiaoyun Liao, Xiaoyu Liu, Xianhai Zeng, Peng Zhang	0
3	Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors 2024 ·ESMO Open ·Bradford A. Perez, Raid Aljumaily, Thomas U. Marron, Michael Shafique, Howard A. Burris, Wade T. Iams, Steven J. Chmura, Jason J. Luke, William J. Edenfield, Davendra Sohal, Xiaoyun Liao, Carsten Boesler, (unknown), (unknown), (unknown), (unknown), (unknown), Scott Antonia	10
4	N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension 2024 ·Cellular & Molecular Biology Letters ·Kang Kang, Jingjing Xiang, (unknown), Yuting Xie, Mengting Zhou, Le Zeng, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Qiang Su, Xiaoyun Liao, Jun Wang, (unknown), Cuilian Liu, Jinglin Tian, Deming Gou	10
5	A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors 2022 ·Clinical Cancer Research ·(unknown), Aurélie Auguste, Xiaoyun Liao, (unknown), K. H. Bauer, Yu-Hsi Lin, (unknown), (unknown), (unknown), Michael Bergmann, (unknown), Leticia Corrales, Anne B. Vogt, Lindsey Hudson, M. Barnes, (unknown), Craig Giragossian, Vladimir Voynov, Paul J. Adam, Susanne Hipp	14
6	Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA 2020 ·SHILAP Revista de lepidopterología ·Zijian Tian, Wei He, (unknown), Xiaoyun Liao, (unknown), Yuan Wu, (unknown)	3
7	An improved Tet-on system in microRNA overexpression and CRISPR/Cas9-mediated gene editing 2019 ·Journal of Animal Science and Biotechnology ·Kang Kang, Lian Huang, Qing Li, Xiaoyun Liao, (unknown), Yi Yang, Jun Luo, Yan Zeng, Li Li, Deming Gou	12
8	Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade 2017 ·Cancer Immunology Research ·Jun Zhou, Kathleen M. Mahoney, Anita Giobbie‐Hurder, Fengmin Zhao, Charles Lee, Xiaoyun Liao, Scott J. Rodig, Jingjing Li, Xinqi Wu, Lisa H. Butterfield, Matthias Piesche, Michael P. Manos, Lauren M. Eastman, Glenn Dranoff, Gordon J. Freeman, F. Stephen Hodi	284
9	Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes 2017 ·Cancer Immunology Research ·Xinqi Wu, Jingjing Li, (unknown), Xiaoyun Liao, Jing Ouyang, Anita Giobbie‐Hurder, Donald P. Lawrence, David F. McDermott, Gëorge F. Murphy, Jun Zhou, Matthias Piesche, Glenn Dranoff, Scott J. Rodig, Margaret A. Shipp, F. Stephen Hodi	58
10	Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy 2016 ·Cancer Immunology Research ·Xinqi Wu, Anita Giobbie‐Hurder, Xiaoyun Liao, Courtney Connelly, (unknown), Jingjing Li, Michael P. Manos, Donald P. Lawrence, David F. McDermott, Mariano Severgnini, Jun Zhou, Evisa Gjini, Ana Lako, Mikel Lipschitz, Christine J. Pak, Sara Abdelrahman, Scott J. Rodig, F. Stephen Hodi	123
11	VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma 2016 ·Cancer Immunology Research ·Xinqi Wu, Anita Giobbie‐Hurder, Xiaoyun Liao, Donald P. Lawrence, David F. McDermott, Jun Zhou, Scott J. Rodig, F. Stephen Hodi	76
12	Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes 2016 ·Cancer Immunology Research ·Vishwajith Sridharan, Evisa Gjini, Xiaoyun Liao, Nicole G. Chau, Robert I. Haddad, Mariano Severgnini, Peter S. Hammerman, Adel K. El‐Naggar, Gordon J. Freeman, F. Stephen Hodi, Scott J. Rodig, Glenn Dranoff, Jonathan D. Schoenfeld	77
13	Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma 2015 ·Cancer Immunology Research ·Sarah Derks, Katie S. Nason, Xiaoyun Liao, Matthew D. Stachler, Kevin X. Liu, Jie Bin Liu, Ewa Sicińska, Michael S. Goldberg, Gordon J. Freeman, Scott J. Rodig, Jon M. Davison, Adam J. Bass	114
14	PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells 2015 ·Cancer Immunology Research ·Kathleen M. Mahoney, Heather H. Sun, Xiaoyun Liao, Ping Hua, Marcella Callea, Edward Greenfield, F. Stephen Hodi, Arlene H. Sharpe, Sabina Signoretti, Scott J. Rodig, Gordon J. Freeman	103
15	Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model 2015 ·Cancer Immunology Research ·David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, Keith L. Ligon, Scott J. Rodig, Shakti Ramkissoon, Kristen L. Jones, Amy Saur Conway, Xiaoyun Liao, Jun Zhou, Patrick Y. Wen, Annick D. Van den Abbeele, F. Stephen Hodi, Lei Qin, Nancy E. Kohl, Arlene H. Sharpe, Glenn Dranoff, Gordon J. Freeman	302
16	Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Mai Yamauchi, Paul Lochhead, Yu Imamura, Aya Kuchiba, Xiaoyun Liao, Zhi Rong Qian, Reiko Nishihara, Teppei Morikawa, Kaori Shima, Kana Wu, Edward L. Giovannucci, Jeffrey A. Meyerhardt, Charles S. Fuchs, Andrew T. Chan, Shuji Ogino	33
17	Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts 2013 ·BMJ ·Hamed Khalili, Ashwin N. Ananthakrishnan, Gauree G. Konijeti, Xiaoyun Liao, (unknown), Charles S. Fuchs, Donna Spiegelman, James M. Richter, Joshua R. Korzenik, Andrew T. Chan	115
18	Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers 2012 ·Clinical Cancer Research ·Yu Imamura, Teppei Morikawa, Xiaoyun Liao, Paul Lochhead, Aya Kuchiba, Mai Yamauchi, Zhi Rong Qian, Reiko Nishihara, Jeffrey A. Meyerhardt, Kevin M. Haigis, Charles S. Fuchs, Shuji Ogino	210
19	Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review 2012 ·Clinical Cancer Research ·Xiaoyun Liao, Teppei Morikawa, Paul Lochhead, Yu Imamura, Aya Kuchiba, Mai Yamauchi, Katsuhiko Nosho, Zhi Rong Qian, Reiko Nishihara, Jeffrey A. Meyerhardt, Charles S. Fuchs, Shuji Ogino	200
20	P63 Expression in Gestational Trophoblastic Disease: Correlation With Proliferation and Apoptotic Dynamics 2009 ·International Journal of Gynecological Pathology ·Huijuan Zhang, (unknown), (unknown), Xiaoyun Liao, Hys Ngan, Any Cheung	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact